ZIM
SCPH

Zacks Investment Management’s scPharmaceuticals SCPH Stock Holding History

Zacks Investment Management’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-32,416
Closed -$294K – 716
2023
Q1 		$294K Hold
32,416
– – ﹤0.01% 524
2022
Q4 		$232K Sell
32,416
-4,573
-12% -$27.9K ﹤0.01% 539
2022
Q3 		$241K Hold
36,989
– – ﹤0.01% 513
2022
Q2 		$178K Hold
36,989
– – ﹤0.01% 551
2022
Q1 		$210K Hold
36,989
– – ﹤0.01% 571
2021
Q4 		$186K Hold
36,989
– – ﹤0.01% 591
2021
Q3 		$246K Hold
36,989
– – ﹤0.01% 553
2021
Q2 		$226K Buy
+36,989
New +$223K ﹤0.01% 553
2021
Q1 		– Sell
-38,539
Closed -$204K – 573
2020
Q4 		$204K Buy
+38,539
New +$302K ﹤0.01% 500

Other funds holding SCPH

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Zacks Investment Management's SCPH Position: Q2 2023 in Review

Zacks Investment Management sold out of scPharmaceuticals (SCPH) in Q2 2023, closing a stake of 32,416 shares — an estimated $294K sold.

Zacks Investment Management first reported a position in SCPH in Q4 2020 and held it in 9 quarters. The position peaked at $294K in Q1 2023. 81 funds tracked by Wall St. Rank hold SCPH as of Q2 2023.

  • Zacks Investment Management reported no remaining scPharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Zacks Investment Management sold 32,416 scPharmaceuticals shares in Q2 2023, an estimated $294K.
  • Zacks Investment Management first reported a position in scPharmaceuticals in Q4 2020 and held it in 9 quarters.
  • Zacks Investment Management's scPharmaceuticals position peaked at $294K in Q1 2023.
  • 81 funds tracked by Wall St. Rank held scPharmaceuticals as of Q2 2023.

Based on Zacks Investment Management's 13F filing for Q2 2023, filed 15 Aug 2023.